20
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diagnostic value of cutaneous manifestation of SARS‐CoV‐2 infection

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          One of the challenging aspects of SARS‐CoV‐2 infection is its diverse multisystemic disease presentation.

          Objectives

          To evaluate the diagnostic value of cutaneous manifestations of SARS‐CoV‐2 infection and investigate their duration and timing in relation to other COVID‐19 symptoms.

          Methods

          We used data from 336 847 UK users of the COVID Symptom Study app to assess the diagnostic value of body rash or an acral rash in SARS‐CoV‐2 infection, and data from an independent online survey of 11 544 respondents to investigate skin‐specific symptoms and collect their photographs.

          Results

          Using data from the app, we show significant association between skin rashes and a positive swab test result (odds ratio 1·67, 95% confidence interval 1·42–1·97). Strikingly, among the respondents of the independent online survey, we found that 17% of SARS‐CoV‐2‐positive cases reported skin rashes as the first presentation, and 21% as the only clinical sign of COVID‐19. Together with the British Association of Dermatologists, we have compiled a catalogue of images of the most common skin manifestations of COVID‐19 from 400 individuals ( https://covidskinsigns.com), which we have made publicly available to assist clinicians in recognition of this early clinical feature of COVID‐19.

          Conclusions

          Skin rashes cluster with other COVID‐19 symptoms, are predictive of a positive swab test, and occur in a significant number of cases, either alone or before other classical symptoms. Recognizing rashes is important in identifying new and earlier cases of COVID‐19.

          Abstract

          What is already known about this topic?

          • Several studies conducted in hospital settings reported that patients with COVID‐19 presented with unusual skin rashes, including urticarial rashes, vesicular lesions and, less frequently, chilblains in fingers or toes.

          What does this study add?

          • We confirmed, in a community‐based setting that also includes milder forms of the disease, that the presence of a skin rash is predictive of SARS‐CoV‐2 infection.

          • We provide a website with photos of skin manifestations to help healthcare professionals in diagnosing COVID‐19.

          • Skin rashes should be taken into account to provide a quick COVID‐19 diagnosis to curb the spread of the disease.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Characteristics of Coronavirus Disease 2019 in China

          Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Real-time tracking of self-reported symptoms to predict potential COVID-19

            A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion of participants who reported loss of smell and taste was higher in those with a positive test result (4,668 of 7,178 individuals; 65.03%) than in those with a negative test result (2,436 of 11,223 participants; 21.71%) (odds ratio = 6.74; 95% confidence interval = 6.31–7.21). A model combining symptoms to predict probable infection was applied to the data from all app users who reported symptoms (805,753) and predicted that 140,312 (17.42%) participants are likely to have COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance

                Bookmark

                Author and article information

                Contributors
                mario.falchi@kcl.ac.uk
                Journal
                Br J Dermatol
                Br J Dermatol
                10.1111/(ISSN)1365-2133
                BJD
                The British Journal of Dermatology
                John Wiley and Sons Inc. (Hoboken )
                0007-0963
                1365-2133
                02 March 2021
                : 10.1111/bjd.19807
                Affiliations
                [ 1 ] Department of Twin Research & Genetic Epidemiology King’s College London London UK
                [ 2 ] Dermatology Department West Herts NHS Trust Watford UK
                [ 3 ] Zoe Global Limited London UK
                [ 4 ] Dermatology Department Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK
                [ 5 ] Dermatology Department Hospital Clinic of Barcelona University of Barcelona Barcelona Spain
                [ 6 ] Institut d’Investigacions Biomèdiques August Pi I Sunyer Barcelona Spain
                [ 7 ] University Hospitals of Derby and Burton NHS Foundation Trust Derby UK
                [ 8 ] School of Biomedical Engineering & Imaging Sciences King’s College London London UK
                Author notes
                [*] [* ] Correspondence

                Mario Falchi.

                Email: mario.falchi@ 123456kcl.ac.uk

                Author information
                https://orcid.org/0000-0003-4144-2019
                https://orcid.org/0000-0002-8285-7627
                https://orcid.org/0000-0003-1337-9745
                https://orcid.org/0000-0002-4910-0489
                https://orcid.org/0000-0002-5646-1004
                Article
                BJD19807
                10.1111/bjd.19807
                8014275
                33448030
                ab332243-6edd-4824-b119-eab728dbef71
                © 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 January 2021
                Page count
                Figures: 3, Tables: 1, Pages: 8, Words: 10983
                Funding
                Funded by: MRC/BHF
                Funded by: CDRF
                Funded by: Wellcome Trust , open-funder-registry 10.13039/100010269;
                Categories
                Epidemiology
                Epidemiology
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.1 mode:remove_FC converted:01.04.2021

                Dermatology
                Dermatology

                Comments

                Comment on this article